Retained Earnings
Bristol-Myers Squibb Retained Earnings increased by 8.2% to $18.29B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.5%, from $16.11B to $18.29B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows a downward trend with a -4.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
A steady increase indicates consistent profitability and successful reinvestment, while a decrease may signal large dividend payouts or net losses.
Detailed definition
Retained earnings represent the cumulative net income of the company that has been reinvested in the business rather tha...
Peer comparison
Mature pharmaceutical companies typically show strong, growing retained earnings as they fund ongoing drug discovery and commercialization.
retained_earningsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.17B | $22.63B | $23.82B | $23.95B | $24.22B | $24.68B | $25.50B | $26.57B | $27.45B | $28.22B | $28.77B | $15.64B | $16.10B | $16.10B | $14.91B | $16.11B | $16.15B | $17.09B | $16.90B | $18.29B |
| QoQ Change | — | +2.1% | +5.3% | +0.5% | +1.1% | +1.9% | +3.4% | +4.2% | +3.3% | +2.8% | +1.9% | -45.6% | +3.0% | -0.0% | -7.4% | +8.0% | +0.3% | +5.8% | -1.2% | +8.2% |
| YoY Change | — | — | — | — | +9.2% | +9.1% | +7.1% | +10.9% | +13.3% | +14.4% | +12.8% | -41.1% | -41.3% | -43.0% | -48.2% | +3.0% | +0.3% | +6.2% | +13.3% | +13.5% |
Retained Earnings at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's retained earnings?
- Bristol-Myers Squibb (BMY) reported retained earnings of $18.29B in Q1 2026.
- How has Bristol-Myers Squibb's retained earnings changed year-over-year?
- Bristol-Myers Squibb's retained earnings increased by 13.5% year-over-year, from $16.11B to $18.29B.
- What is the long-term trend for Bristol-Myers Squibb's retained earnings?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's retained earnings has grown at a -4.5% compound annual growth rate (CAGR), from $21.28B to $16.90B.
- What does retained earnings mean?
- The total profits the company has kept and reinvested since its inception.